VivoSim's NAMkind Models Validated for Predicting ADC Toxicity and Side Effects

VivoSim Labs has validated its NAMkind liver and intestine models to predict toxicity and side effects of antibody drug conjugates (ADCs). The models have shown close correlation with clinical results and can help screen out toxicities during lead candidate optimization or earlier stages, potentially resulting in greater success in the clinic with limited side effect profiles. NAMkind liver and small intestine toxicology services are now available globally.